BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33183792)

  • 21. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.
    Samaratunga H; Egevad L; Thunders M; Iczskowski KA; van der Kwast T; Kristiansen G; Pan CC; Leite KRM; Evans A; Clouston D; Kenwright DN; Bethwaite PB; Malone G; Wood S; Yaxley JW; Delahunt B
    Pathology; 2022 Dec; 54(7):842-847. PubMed ID: 36270849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A metachronous, atypical, multifocal renal oncocytoma with a concomitant renal cell carcinoma of the contralateral side and bilateral multifocal oncocytomas: two case reports and review of literature.
    Burger M; Denzinger S; Filbeck T; Hartmann A; Rössler W; Hammerschmied C
    ScientificWorldJournal; 2005 Jul; 5():545-9. PubMed ID: 16075151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy for hybrid oncocytic/chromophobe renal cell tumors by exploiting an immunohistochemical and histochemical combined panel.
    Roncati L; Barbolini G; Maiorana A
    Diagnosis (Berl); 2017 Jun; 4(2):109-110. PubMed ID: 29536916
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of renal oncocytoma with focus on clinical and pathobiological aspects.
    Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H
    Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review.
    McCroskey Z; Sim SJ; Selzman AA; Ayala AG; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():32-36. PubMed ID: 28807339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
    Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
    Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unclassified Oncocytic Renal Neoplasm with Rib and Liver Metastases: Metastatic Oncocytoma?
    Tomaszewski Z; Littler Y
    Int J Surg Pathol; 2022 Oct; 30(7):810-815. PubMed ID: 35274993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
    Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
    Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
    Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
    Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.
    McHugh JB; Hoschar AP; Dvorakova M; Parwani AV; Barnes EL; Seethala RR
    Head Neck Pathol; 2007 Dec; 1(2):123-31. PubMed ID: 20614263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oncocytic tumours of the kidney-new differential diagnoses].
    Polifka I; Ohashi R; Moch H
    Pathologe; 2021 Nov; 42(6):551-559. PubMed ID: 34468818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal oncocytoma--are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis.
    Haifler M; Copel L; Sandbank J; Lang E; Raz O; Leibovici D; Lindner A; Zisman A
    Urol Oncol; 2012; 30(4):362-8. PubMed ID: 20171908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.